On November 6, 2025, the Trump administration announced new pricing and coverage agreements with Eli Lilly and Novo Nordisk for widely used glucagon-like peptide-1 (GLP-1) receptor agonists, including tirzepatide (Mounjaro®, Zepbound®) and semaglutide (Ozempic®, Wegovy®). These agreements aim to lower out-of-pocket costs for some patients and expand access under federal health programs beginning in 2026. […]
Tag Archives: ATLMed
Rural communities across the United States continue to face deep, long-standing healthcare challenges: long travel distances to clinics, shortages of specialists, hospital closures, and limited access to timely, high-quality care. These barriers contribute to higher rates of chronic disease, later diagnoses, and poorer health outcomes for millions of rural residents. A recent perspective in the […]
In an era where technology meets everyday life, digital health tools are proving to be more than just convenient—they can be lifesaving. A recent case published in the New England Journal of Medicine (NEJM) highlights a powerful example: a 70-year-old man whose smartwatch and smart mattress sensor detected a dangerously slow heart rate, long before […]
A group of twelve former commissioners of the U.S. Food and Drug Administration (FDA)—spanning multiple administrations and political parties—has issued an unprecedented public warning about recent changes to the agency’s vaccine regulatory framework. Their commentary, published in the New England Journal of Medicine (NEJM), argues that these policy shifts threaten the longstanding scientific and regulatory […]
A Night of Excellence, Legacy, and Leadership in Atlanta’s Medical Community The Atlanta Medical Association is proud to announce the 2026 Heritage Fund Scholarship & Awards Gala, on Sat., Feb., 28, 2026. This elegant evening is dedicated to honoring excellence in medicine, supporting the next generation of healthcare leaders, and celebrating the legacy of physicians […]
The Make America Healthy Again (MAHA) Commission has brought long-overdue national attention to the health and well-being of U.S. children — marking the first White House–level focus on child health since 1971. While this renewed interest is welcome, a closer review shows that the Commission’s strategy falls short of addressing the core conditions driving poor […]
Diabetes is one of the world’s fastest-growing health challenges — and its impact is felt profoundly in the workplace. According to the IDF Diabetes Atlas, 589 million people were living with diabetes in 2024, and 70% were of working age. Yet, in most workplaces, meaningful diabetes support is still missing. As World Diabetes Day 2025 […]
Access to early prenatal care is a cornerstone of healthy pregnancies. Getting care within the first trimester (the first 12 weeks) allows providers to assess maternal and fetal health, identify risk factors, initiate needed care, and help set the stage for optimal outcomes. Yet in the United States, a sizeable proportion of expectant mothers do […]
Breast cancer remains the most frequently diagnosed cancer among women worldwide, affecting millions of families each year and placing a tremendous emotional and economic burden on communities. While public health efforts have made progress in promoting screening, early detection, and treatment, one area continues to lag behind the science: the connection between diet and women’s […]
Celiac disease is far more than a dietary intolerance. It is a serious autoimmune disorder in which the body’s immune system attacks the small intestine after exposure to gluten — a protein naturally found in wheat, barley, and rye. For people living with celiac disease, even a single crumb of gluten-containing food can trigger inflammation […]










